0001189727-15-000002.txt : 20150213 0001189727-15-000002.hdr.sgml : 20150213 20150213180223 ACCESSION NUMBER: 0001189727-15-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150211 FILED AS OF DATE: 20150213 DATE AS OF CHANGE: 20150213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ICU MEDICAL INC/DE CENTRAL INDEX KEY: 0000883984 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330022692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 BUSINESS PHONE: 949-366-2183 MAIL ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BURCAR ALISON D CENTRAL INDEX KEY: 0001189727 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34634 FILM NUMBER: 15616767 MAIL ADDRESS: STREET 1: C/O ICU MEDICAL INC STREET 2: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 FORMER NAME: FORMER CONFORMED NAME: BRUMMETT BURCAR ALISON DATE OF NAME CHANGE: 20020916 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2015-02-11 0 0000883984 ICU MEDICAL INC/DE ICUI 0001189727 BURCAR ALISON D 951 CALLE AMANECER SAN CLEMENTE CA 92673 0 1 0 0 Vice President and Gen'l Mgr. Common Stock 0.0 2015-02-11 4 A 0 3549.0 0.0 A 2018-02-11 Common Stock 3549 3549 D Non-Qualified Stock Option (right to buy) 88.76 2015-02-11 4 A 0 13219.0 88.76 A 2025-02-11 Common Stock 13219 13219 D These securities are Restricted Stock Units. There is neither a purchase price nor an exercise price for the Restricted Stock Units. One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. One-third of the shares shall vest on each of the first, second, and third anniversaries of the grant date. The vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and thirty percent of the exercise price per share for thirty consecutive trading days. The appreciation must occur within four years from the grant date. By: Lynn Ehrhart For: Alison D. Burcar 2015-02-13